Bausch Health Companies | VRX - المديونيات المتداولة





المديونيات المتداولة تغيير تاريخ
Amgen USD 24.96B 534M 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Aurora Cannabis CAD 66.93M 79M 2026-03
Bausch Health Companies USD 4.53B 350M 2026-03
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Danaher USD 8.1B 645M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novo Nordisk DKK 225.16B 9.5B 2026-03
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Zoetis USD 2.05B 182M 2026-03